Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00721994 · ClinicalTrials.gov registry record
Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects
A clinical trial of Rheumatoid Arthritis and Osteoarthritis, sponsored by Corin.
- Completed
- Registry status
- 231
- Enrollment target
- 5
- Study locations
NCT00721994: Completed study of Rheumatoid Arthritis and Osteoarthritis, sponsored by Corin.
NCT00721994 is a study of Rheumatoid Arthritis and Osteoarthritis that has completed, run by Corin. The registered enrollment target is 231 participants, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (95% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00721994, a study of Rheumatoid Arthritis and Osteoarthritis, has completed, sponsored by Corin.
- COMPLETED
- Registry status
- 231 participants
- Enrollment target
- 5
- Study locations
Study Summary
primary endpoint of this Study is maintenance of "at least good clinical status" for a period of 10 years following initial implantation among Cormet procedures enrolled inthe pre-market IDE.
Conditions Studied
Interventions
- DEVICE Cormet Hip Resurfacing System
Study Locations (5)
Florida
- Space Coast Orthopaedics Ctr. - Merritt Island
- Kennedy White Orthopedics - Sarasota
Illinois
- Southern Illinois University School of Medicine - Springfield
Maryland
- Good Samaritan Hospital - Baltimore
Ohio
- Cleveland Center for Joint Reconstruction - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2008-05 |
| Est. Completion | 2017-08 |
What the finished NCT00721994 record still lists
NCT00721994 is an observational study that tracks outcomes without assigning an intervention. The registered 231 participants enrollment target is mid-sized for trials with a published cap, below the 4,689-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (95% lower).
The record links to 3 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Cormet Hip Resurfacing System is the first listed.
NCT00721994 lists 5 locations in 4 states (Florida, Illinois, Maryland).
Frequently Asked Questions
What is clinical trial NCT00721994 about?
NCT00721994 is a clinical study titled "Post-PMA Approval Study: 10 Year Follow-Up IDE Subjects". primary endpoint of this Study is maintenance of "at least good clinical status" for a period of 10 years following initial implantation among Cormet procedures enrolled inthe pre-market IDE.
What is the current status of trial NCT00721994?
This trial is currently completed. The enrollment target is 231 participants. The study started on 2008-05. Estimated completion is 2017-08.
What conditions does trial NCT00721994 study?
This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Avascular Necrosis.
What interventions are being tested in trial NCT00721994?
The interventions under investigation include: Cormet Hip Resurfacing System (DEVICE).
Who is sponsoring clinical trial NCT00721994?
This trial is sponsored by Corin, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00721994 being conducted?
This trial has 5 study locations across Florida, Illinois, Maryland, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Rheumatoid Arthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00721994's enrollment target sits among peer trials
231 78th of 197 higher than 120 of 197 other Rheumatoid Arthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Rheumatoid Arthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Rheumatology Diet Study
RECRUITING
-
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
RECRUITING · Phase 1
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Creating Health Course Study for People With Rheumatological Conditions
RECRUITING · NA
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Study of GS-0151 in Participants With Rheumatoid Arthritis
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04077099 · 231 participants · Phase 1
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
- NCT05019495 · 231 participants · NA
Optimizing Tobacco Treatment Delivery for People Living With HIV
- NCT06023589 · 231 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- NCT06734351 · 231 participants · Phase 3
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia